Biophysical Journal 70: 2110-2119 (1996)
© 1996 the Biophysical Society

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tinker, A Articles by Williams, A J Search for Related Content PubMed PubMed Citation Articles by Tinker, A Articles by Williams, A J

Electrophysiological effects of ryanodine derivatives on the sheep cardiac sarcoplasmic reticulum calcium-release channel.

Cardiac Medicine, National Heart and Lung Institute, Imperial College, University of London, London, England.

ABSTRACT

We have examined the effects of a number of derivatives of ryanodine on K+ conduction in the Ca2+ release channel purified from sheep cardiac sarcoplasmic reticulum (SR). In a fashion comparable to that of ryanodine, the addition of nanomolar to micromolar quantities to the cytoplasmic face (the exact amount depending on the derivative) causes the channel to enter a state of reduced conductance that has a high open probability. However, the amplitude of that reduced conductance state varies between the different derivatives. In symmetrical 210 mM K+, ryanodine leads to a conductance state with an amplitude of 56.8 +/- 0.5% of control, ryanodol leads to a level of 69.4 +/- 0.6%, ester A ryanodine modifies to one of 61.5 +/- 1.4%, 9,21-dehydroryanodine to one of 58.3 +/- 0.3%, 9 beta,21beta-epoxyryanodine to one of 56.8 +/- 0.8%, 9-hydroxy-21-azidoryanodine to one of 56.3 +/- 0.4%, 10-pyrroleryanodol to one of 52.2 +/- 1.0%, 3-epiryanodine to one of 42.9 +/- 0.7%, CBZ glycyl ryanodine to one of 29.4 +/- 1.0%, 21-p-nitrobenzoyl-amino-9-hydroxyryanodine to one of 26.1 +/- 0.5%, beta-alanyl ryanodine to one of 14.3 +/- 0.5%, and guanidino-propionyl ryanodine to one of 5.8 +/- 0.1% (chord conductance at +60 mV, +/- SEM). For the majority of the derivatives the effect is irreversible within the lifetime of a single-channel experiment (up to 1 h). However, for four of the derivatives, typified by ryanodol, the effect is reversible, with dwell times in the substate lasting tens of seconds to minutes. The effect caused by ryanodol is dependent on transmembrane voltage, with modification more likely to occur and lasting longer at +60 than at -60 mV holding potential. The addition of concentrations of ryanodol insufficient to cause modification does not lead to an increase in single-channel open probability, such as has been reported for ryanodine. At concentrations of > or = 500 mu M, ryanodine after initial rapid modification of the channel leads to irreversible closure, generally within a minute. In contrast, comparable concentrations of beta-alanyl ryanodine do not cause such a phenomenon after modification, even after prolonged periods of recording (>5 min). The implications of these results for the site(s) of interaction with the channel protein and mechanism of the action of ryanodine are discussed. Changes in the structure of ryanodine can lead to specific changes in the electrophysiological consequences of the interaction of the alkaloid with the sheep cardiac SR Ca2+ release channel.

This article has been cited by other articles:

				B. Tanna, W. Welch, L. Ruest, J. L. Sutko, and A. J. Williams The Interaction of an Impermeant Cation with the Sheep Cardiac RyR Channel Alters Ryanoid Association Mol. Pharmacol., June 1, 2006; 69(6): 1990 - 1997. [Abstract] [Full Text] [PDF]

				K. M. Ranatunga, T. M. Moreno-King, B. Tanna, R. Wang, S. R. W. Chen, L. Ruest, W. Welch, and A. J. Williams The Gln4863Ala Mutation within a Putative, Pore-Lining Trans-Membrane Helix of the Cardiac Ryanodine Receptor Channel Alters Both the Kinetics of Ryanoid Interaction and the Subsequent Fractional Conductance Mol. Pharmacol., September 1, 2005; 68(3): 840 - 846. [Abstract] [Full Text] [PDF]

				B. Tanna, W. Welch, L. Ruest, J. L. Sutko, and A. J. Williams Voltage-Sensitive Equilibrium between Two States within a Ryanoid-Modified Conductance State of the Ryanodine Receptor Channel Biophys. J., April 1, 2005; 88(4): 2585 - 2596. [Abstract] [Full Text] [PDF]

				C. S. Hui, H. R. Besch Jr., and K. R. Bidasee Effects of Ryanoids on Spontaneous and Depolarization-Evoked Calcium Release Events in Frog Muscle Biophys. J., July 1, 2004; 87(1): 243 - 255. [Abstract] [Full Text] [PDF]

				R. Wang, L. Zhang, J. Bolstad, N. Diao, C. Brown, L. Ruest, W. Welch, A. J. Williams, and S. R. W. Chen Residue Gln4863 within a Predicted Transmembrane Sequence of the Ca2+ Release Channel (Ryanodine Receptor) Is Critical for Ryanodine Interaction J. Biol. Chem., December 19, 2003; 278(51): 51557 - 51565. [Abstract] [Full Text] [PDF]

				B. Tanna, W. Welch, L. Ruest, J. L. Sutko, and A. J. Williams An Anionic Ryanoid, 10-O-succinoylryanodol, Provides Insights into the Mechanisms Governing the Interaction of Ryanoids and the Subsequent Altered Function of Ryanodine-receptor Channels J. Gen. Physiol., May 27, 2003; 121(6): 551 - 561. [Abstract] [Full Text] [PDF]

				K. R. Bidasee, L. Xu, G. Meissner, and H. R. Besch Jr. Diketopyridylryanodine Has Three Concentration-dependent Effects on the Cardiac Calcium-release Channel/Ryanodine Receptor J. Biol. Chem., April 11, 2003; 278(16): 14237 - 14248. [Abstract] [Full Text] [PDF]

				R. G. Tsushima, J. E. Kelly, and J. A. Wasserstrom Subconductance Activity Induced by Quinidine and Quinidinium in Purified Cardiac Sarcoplasmic Reticulum Calcium Release Channels J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 729 - 737. [Abstract] [Full Text] [PDF]

				K. R. Bidasee, U. D. Dincer, and H. R. Besch Jr. Ryanodine Receptor Dysfunction in Hearts of Streptozotocin-Induced Diabetic Rats Mol. Pharmacol., December 1, 2001; 60(6): 1356 - 1364. [Abstract] [Full Text] [PDF]

				H. Masumiya, P. Li, L. Zhang, and S. R. W. Chen Ryanodine Sensitizes the Ca2+ Release Channel (Ryanodine Receptor) to Ca2+ Activation J. Biol. Chem., October 19, 2001; 276(43): 39727 - 39735. [Abstract] [Full Text] [PDF]

				K. Emanuel, U. Mackiewicz, and B. Lewartowski On the source of Ca2+ activating the tonic component of contraction of myocytes of guinea pig heart Cardiovasc Res, October 1, 2001; 52(1): 76 - 83. [Abstract] [Full Text] [PDF]

				K. R. Bidasee, A. Maxwell, W. F. Reynolds, V. Patel, and H. R. Besch Jr. Tectoridins Modulate Skeletal and Cardiac Muscle Sarcoplasmic Reticulum Calcium-Release Channels J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1074 - 1083. [Abstract] [Full Text]

				K. R. Bidasee and H. R. Besch Jr. Structure-Function Relationships among Ryanodine Derivatives. PYRIDYL RYANODINE DEFINITIVELY SEPARATES ACTIVATION POTENCY FROM HIGH AFFINITY J. Biol. Chem., May 15, 1998; 273(20): 12176 - 12186. [Abstract] [Full Text] [PDF]

				R. Zucchi and S. Ronca-Testoni The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52. [Abstract] [Full Text] [PDF]

				J. L. Sutko, J. A. Airey, W. Welch, and L. Ruest The Pharmacology of Ryanodine and Related Compounds Pharmacol. Rev., March 1, 1997; 49(1): 53 - 98. [Abstract] [Full Text] [PDF]